Is LBPS or JEPQ a better dividend investment in 2026?

LBPS currently yields 121.21% with a 5% 5-year dividend growth rate. JEPQ yields 11.47% with 5% growth. The better choice depends on your goal: LBPS offers higher current income.

What is the dividend yield difference between LBPS and JEPQ?

LBPS has a forward dividend yield of 121.21% ($2.00/share annually). JEPQ yields 11.47% ($6.16/share annually). The yield gap is 109.74 percentage points.

Home › Compare › LBPS vs JEPQ

LBPS vs JEPQ: Dividend Comparison 2026

LBPS yields 121.21% · JEPQ yields 11.47%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LBPS wins by $8.90M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LBPS

● Live price

121.21%

Share price

$1.65

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.95M

Annual income

$3,410,602.48

Full LBPS calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.47%

Share price

$53.77

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.8K

Annual income

$2,269.18

Full JEPQ calculator →

Portfolio growth — LBPS vs JEPQ

📍 LBPS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LBPS	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LBPS + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LBPS pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBPS

Annual income on $10K today (after 15% tax)

$10,303.03/yr

After 10yr DRIP, annual income (after tax)

$2,899,012.11/yr

JEPQ

Annual income on $10K today (after 15% tax)

$974.55/yr

After 10yr DRIP, annual income (after tax)

$1,928.80/yr

At 15% tax rate, LBPS beats the other by $2,897,083.31/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBPS + JEPQ for your $10,000?

LBPS: 50%JEPQ: 50%

100% JEPQ50/50100% LBPS

Portfolio after 10yr

$4.50M

Annual income

$1,706,435.83/yr

Blended yield

37.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on LBPS right now

LBPS

Analyst Ratings

Buy

Hold

Consensus: Buy

JEPQ

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBPS buys

JEPQ buys

No recent congressional trades found for LBPS or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLBPSJEPQ

Forward yield	121.21% ✓	11.47%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$8.95M	$45.8K ✓
Annual income after 10y	$3,410,602.48 ✓	$2,269.18
Total dividends collected	$8.14M	$17.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: LBPS vs JEPQ ($10,000, DRIP)

Year	LBPS Portfolio	LBPS Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$22,821	$12,121.21	$11,967	$1,146.53	+$10.9K → LBPS
2	$50,271	$25,852.41	$14,216	$1,268.02	+$36.1K → LBPS
3	$107,013	$53,222.70	$16,774	$1,392.20	+$90.2K → LBPS
4	$220,388	$105,884.01	$19,667	$1,518.21	+$200.7K → LBPS
5	$439,612	$203,797.23	$22,925	$1,645.21	+$416.7K → LBPS
6	$850,309	$379,924.02	$26,578	$1,772.40	+$823.7K → LBPS
7	$1,596,614	$686,783.92	$30,656	$1,899.04	+$1.57M → LBPS
8	$2,913,579	$1,205,201.50	$35,194	$2,024.45	+$2.88M → LBPS
9	$5,172,959	$2,055,429.68	$40,228	$2,148.01	+$5.13M → LBPS
10	$8,945,669	$3,410,602.48	$45,796	$2,269.18	+$8.90M → LBPS

LBPS vs JEPQ: Complete Analysis 2026

LBPS — Stock

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

Full LBPS Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this LBPS vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBPS vs SCHD LBPS vs JEPI LBPS vs O LBPS vs KO LBPS vs MAIN LBPS vs XYLD LBPS vs QYLD LBPS vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.